Key Insights

Highlights

Success Rate

82% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

7.1%

2 terminated out of 28 trials

Success Rate

81.8%

-4.7% vs benchmark

Late-Stage Pipeline

11%

3 trials in Phase 3/4

Results Transparency

11%

1 of 9 completed with results

Key Signals

1 with results82% success

Data Visualizations

Phase Distribution

24Total
Not Applicable (17)
P 1 (2)
P 2 (2)
P 3 (3)

Trial Status

Recruiting9
Completed9
Unknown5
Terminated2
Suspended1
Withdrawn1

Trial Success Rate

81.8%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (28)

Showing 20 of 20 trials
NCT06381882Enrolling By Invitation

The Role of the Human Microbiome in Patients After Pancreatic Resection.

NCT05843877Phase 3RecruitingPrimary

Pancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula

NCT05289830Phase 2Terminated

Escitalopram to Placebo in Patients With Localized Pancreatic Cancer

NCT07230509Phase 2Recruiting

Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate

NCT07155525Phase 3Recruiting

Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas

NCT07132541Phase 1Recruiting

Saleh's Technique for Pancreaticojejunostomy (Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate)

NCT03724994Completed

Chemotherapy, Host Response and Molecular Dynamics in Periampullary Cancer

NCT07009119Not ApplicableRecruiting

Laparoscopic Pancreaticoduodenectomy

NCT07081360Phase 3Recruiting

Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer

NCT06069297Not ApplicableRecruiting

Prehabilitation in Pancreatic Surgery

NCT07022015Not ApplicableRecruiting

Predictive Risk Factors for Pancreatic Fistula After Pancreaticoduodenectomy

NCT04985071CompletedPrimary

Complication of Pancreatic Fistula and Bleeding After Pancreaticoduodenectomy in Treatment Periampullary Cancer

NCT04714983Phase 1Suspended

DNX-2440 for Resectable Colorectal Liver Metastasis

NCT01913275Not ApplicableWithdrawnPrimary

Comparison Between Endoscopic Stenting and Cholecystojejunostomy for PreoperativeDrainage Before Pancreaticoduodenectomy

NCT06009224Not ApplicableUnknownPrimary

The Effect of ERAS on Pancreaticoduodenectomy (v2.0)

NCT03870698Not ApplicableCompleted

Comparison of Functional Recovery Between Laparoscopic and Open Pancreaticoduodenectomy

NCT05155878Recruiting

Prognostic Factors in Periampullary Tumors and Cysts

NCT04311047Not ApplicableTerminated

Preoperative Detection of Lymph Node Metastases in Pancreatic and Periampullary Carcinoma Using USPIO MRI

NCT03138213Not ApplicableUnknown

Comparing Total Laparoscopic Versus Open Pancreaticoduodenectomy

NCT04401722Not ApplicableCompletedPrimary

Clinical Impact of Altitude Level on Surgical Outcomes of Pancreaticoduodenectomy

Scroll to load more

Research Network

Activity Timeline